Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric NTRK Fusion-Positive Solid Tumors (Children's Oncology Group ADVL1823)

  • Theodore W. Laetsch
  • , Stephan Voss
  • , Kathleen Ludwig
  • , David Hall
  • , Donald A. Barkauskas
  • , Steven G. Dubois
  • , Joan Ronan
  • , Erin R. Rudzinski
  • , Amanda Memken
  • , Krystal Robinson
  • , Joel Sorger
  • , Joel M. Reid
  • , Teena Bhatla
  • , Brian D. Crompton
  • , Alanna J. Church
  • , Elizabeth Fox
  • , Brenda J. Weigel

Producción científica: Articlerevisión exhaustiva

Huella

Profundice en los temas de investigación de 'Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric NTRK Fusion-Positive Solid Tumors (Children's Oncology Group ADVL1823)'. En conjunto forman una huella única.
Clasificar por

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry